
558447-26-0 Mavorixafor
Product name:Mavorixafor
CAS:558447-26-0
MF:C21H27N5
MW:349.47
EINECS:
MDL No.:MFCD11977316
Properties
Appearance brown oil
Melting point:108-110℃
Boiling point:597.0±50.0 °C
Density 1.21
storage temp. Store at -20°C
Application:
Mavorixafur is a selective CXC chemokine receptor 4 (CXCR4) antagonist primarily used for the treatment of WHIM syndrome patients aged 12 years and older. Mavorixafur inhibits the excessive transmission of the CXCR4/CXCL12 signaling pathway by blocking the binding between CXCR4 and its ligand CXCL12 (also known as SDF-1), thereby increasing the number of mature neutrophils and lymphocytes in the bloodstream and helping to improve the patient's immune function.
Synonyms:
558447-26-0
AMD-070
Mavorixafor
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
X4P-001
N-(1H-benzimidazol-2-ylmethyl)-N-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
1,4-BUTANEDIAMINE, N-(1H-BENZIMIDAZOL-2-YLMETHYL)-N-((8S)-5,6,7,8-TETRAHYDRO-8-QUINOLINYL)-
N'-((1H-benzo(d)imidazol-2-yl)methyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
Hot Tags: 558447-26-0 mavorixafor, China 558447-26-0 mavorixafor manufacturers, suppliers, api role based access control api integration, api restaurant api integration, api machine learning integration, api banking api integration, Cefprozil hydrate, api order management api integration

